Walter Reinisch

5PUBLICATIONS
29CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersAgricultural molecular engineering of nucleic acids and proteinsClinical chemistry (incl. diagnostics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 02, 2026
Infliximab and Upadacitinib Demonstrate Superior Early Onset of Efficacy in Biologic-Naïve Ulcerative Colitis With Severe Endoscopic Disease.

Emily C L Wong, Vipul Jairath, Parambir S Dulai

|Jan 08, 2026
Clinical Trial Endpoints for Perianal Fistulizing Crohn's Disease.

Walter Reinisch, Raja Atreya, Florian Rieder

|Aug 04, 2025
Ultraprocessed Grains and Risk of Inflammatory Bowel Disease: Results From the Prospective Urban Rural Epidemiology Study.

Neeraj Narula, Emily C L Wong, Andrew Mente

|Feb 25, 2025
A Review of the Modified Multiplier of Simple Endoscopic Score for Crohn's Disease and How to Use It in Clinical Trials and Practice.

Peter W Huan, Akash Mehta, Emily C L Wong

|Jan 18, 2024
Delayed Ustekinumab and Adalimumab Responders Have Similar Outcomes as Early Responders in Biologic-Naïve Crohn's Disease.

Neeraj Narula, Emily C L Wong, Parambir S Dulai

Pageof 1